Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
711.50    -7.50 (-1.04%)
Bid:
712.50
Ask:
714.00
Spread: 1.50 (0.211%)
Market Cap: £1.21b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Form 8.3 - Bodycote Plc

26 May 2026 14:00

RNS Number : 7512F
Franklin Resources, Inc
26 May 2026
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Franklin Resources, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Bodycote plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22 May 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

17 3/11p ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,427,398

3.17

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

5,427,398

3.17

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

none

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

none

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Date of disclosure:

26 May 2026

Contact name:

Natalia Krzeminska

Telephone number:

48-61-667-92-13 subsshholder@franklintempleton.com

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUNVURNWUVUAR
Date   Source Headline
28th Feb 20177:00 amRNSFinal Results
27th Feb 20179:00 amPRNChange of Director's particulars
17th Feb 20171:08 pmPRNHolding(s) in Company
13th Feb 20175:13 pmPRNHolding(s) in Company
1st Feb 20174:28 pmPRNHolding(s) in Company
31st Jan 20175:00 pmPRNTotal Voting Rights
11th Jan 20172:54 pmPRNHolding(s) in Company
30th Dec 201612:00 pmPRNTotal Voting Rights
23rd Dec 201611:59 amPRNHolding(s) in Company
16th Dec 20164:06 pmPRNDirectorate Change
12th Dec 201612:30 pmPRNChange in Director's Particulars
7th Dec 201610:24 amPRNDirector/PDMR Shareholding
30th Nov 20165:00 pmPRNTotal Voting Rights
18th Nov 20167:00 amRNSTrading Update
10th Nov 20168:00 amPRNChange in Director's Particulars
7th Nov 201611:01 amPRNDirector/PDMR Shareholding
31st Oct 20164:00 pmPRNTotal Voting Rights
28th Oct 20163:40 pmPRNHolding(s) in Company
27th Oct 201611:47 amPRNHolding(s) in Company
20th Oct 20164:42 pmPRNDirector/PDMR Shareholding
12th Oct 20167:00 amPRNAppointment of Group Finance Director
10th Oct 20165:22 pmPRNHolding(s) in Company
10th Oct 20168:00 amPRNHolding(s) in Company
7th Oct 20168:12 amPRNChange in Director's Particulars
30th Sep 20165:00 pmPRNTotal Voting Rights
13th Sep 20167:00 amPRNBoard Appointment
9th Sep 20164:34 pmPRNHolding(s) in Company
31st Aug 20165:05 pmPRNTotal Voting Rights
24th Aug 20169:33 amRNSHolding(s) in Company
16th Aug 201610:16 amRNSDirector/PDMR Shareholding
29th Jul 20165:00 pmPRNTotal Voting Rights
28th Jul 20167:00 amRNSHalf Yearly Report
13th Jul 201612:31 pmPRNHolding(s) in Company
8th Jul 20165:20 pmPRNHolding(s) in Company
8th Jul 20169:33 amPRNHolding(s) in Company
7th Jul 20163:16 pmPRNHolding(s) in Company
30th Jun 20165:00 pmPRNTotal Voting Rights
21st Jun 20164:16 pmPRNDirector/PDMR Shareholding
14th Jun 20165:12 pmPRNDirector/PDMR Shareholding
10th Jun 20164:00 pmPRNDirector/PDMR Shareholding
10th Jun 20163:25 pmPRNDirector/PDMR Shareholding
6th Jun 20164:45 pmPRNDirector/PDMR Shareholding
27th May 20163:34 pmPRNDirectorate Change
27th May 20162:14 pmRNSResults of AGM
27th May 20167:00 amRNSTrading Statement
9th May 20164:30 pmPRNChange in Director's Particulars
3rd May 20164:47 pmPRNDirector/PDMR Shareholding
29th Apr 20165:00 pmPRNTotal Voting Rights
25th Apr 20165:42 pmPRNDirector/PDMR Shareholding
19th Apr 20165:20 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.